Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.

Ghafuri DL, Chaturvedi S, Rodeghier M, Stimpson SJ, McClain B, Byrd J, DeBaun MR
Pediatr Blood Cancer. 2017 64 (7)

PMID: 28035747 · DOI:10.1002/pbc.26401

MeSH Terms (14)

Adolescent Anemia, Sickle Cell Antisickling Agents Blood Flow Velocity Cerebrovascular Circulation Child Child, Preschool Cohort Studies Female Humans Hydroxyurea Male Retrospective Studies Ultrasonography, Doppler, Transcranial

Connections (2)

This publication is referenced by other Labnodes entities:

Links